Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Melanoma 30Leukemia, Lymphocytic, Chronic, B-Cell 28Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 18Myelodysplastic Syndromes 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Multiple Myeloma 15Neoplasm Metastasis 13Lymphoma, Follicular 12Skin Neoplasms 11Lymphoma, Mantle-Cell 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Congenital Abnormalities 10Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Myeloproliferative Disorders 8Blast Crisis 8Anemia, Refractory, with Excess of Blasts 8Neoplasms, Plasma Cell 7Lymphoma, Large B-Cell, Diffuse 7Kidney Neoplasms 7Burkitt Lymphoma 7Primary Myelofibrosis 6Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Large-Cell, Immunoblastic 6

Interventions

Radiotherapy 4Cisplatin 4Radiation 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3fludarabine phosphate 2fludarabine 2entinostat 2aldesleukin 2Trastuzumab 2Platinum 2Cyclophosphamide 2Congresses as Topic 2Brachytherapy 21,2-diaminocyclohexaneplatinum II citrate 2tipifarnib 1bintrafusp alfa protein, human 1adavosertib 1Watchful Waiting 1Therapeutics 1Ritonavir 1Radiotherapy, Intensity-Modulated 1Psychiatric Rehabilitation 1Paclitaxel 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Vaginal Neoplasms × fludarabine phosphate × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡